Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ITGB2 | P05107 | 2/20 | 0.46 |
| ▸ | ICAM1 | P05362 | 2/20 | 0.46 |
| ▸ | ITGAL | P20701 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 6/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16401 | 1.00 | ECE1 (0.50) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL30052291 | 1.00 | ECE1 (0.50) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL5613494 | 0.93 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL7022643 | 0.93 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL618873 | 0.93 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL546997 | 0.93 | ECE1 (0.53) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL9015921 | 0.87 | MEN1 (0.44) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL151539 | 0.87 | MEN1 (0.44) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL15442513 | 0.87 | ECE1 (0.44) | ECE1MEN1KMT2AITGB2ICAM1 | |
| SCHEMBL8470054 | 0.87 | ECE1 (0.44) | ECE1MEN1KMT2AITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683674-A1 | COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING | Yale University (US) | 2026-01-28 | — | — | EP | claimed |
| CN-118703593-A | Argininase quantitative detection kit, argininase qualitative detection kit and use method thereof | 武汉简为医疗科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| WO-2024197302-A1 | COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING | YALE UNIVERSITY (US) | 2024-09-26 | — | — | WO | claimed |
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ASTRAZENECA AB (SE) | 2026-02-05 | — | — | US | disclosed |
| EP-4683674-A1 | COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING | Yale University (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-4655007-A1 | ANTIBODY OLIGONUCLEOTIDE CONJUGATES | Yale University (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-4642488-A1 | ANTIBODY DRUG CONJUGATES | Yale University (US) | 2025-11-05 | — | — | EP | disclosed |
| CN-118703593-A | Argininase quantitative detection kit, argininase qualitative detection kit and use method thereof | 武汉简为医疗科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| WO-2024197302-A1 | COMPOSITIONS AND METHODS FOR DELIVERING ANTIBODY OLIGONUCLEOTIDE CONJUGATES FOR EXON SKIPPING | YALE UNIVERSITY (US) | 2024-09-26 | — | — | WO | disclosed |
| US-20240307428-A1 | SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2024-09-19 | — | — | US | disclosed |
| WO-2024158824-A1 | ANTIBODY OLIGONUCLEOTIDE CONJUGATES | YALE UNIVERSITY (US) | 2024-08-02 | — | — | WO | disclosed |
| US-12029748-B2 | Synergistic composition for maintenance of healthy balance of microflora | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2024-07-09 | — | — | US | disclosed |
| WO-2024145398-A1 | ANTIBODY DRUG CONJUGATES | YALE UNIVERSITY (US) | 2024-07-04 | — | — | WO | disclosed |
| CN-107236021-B | Synthetic method of polypeptide derivative | 湖北泓肽生物科技有限公司 | 2020-12-01 | — | — | CN | disclosed |
| WO-2018160158-A1 | SYNERGISTIC COMPOSITION FOR MAINTENANCE OF HEALTHY BALANCE OF MICROFLORA | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2018-09-07 | — | — | WO | disclosed |
| EP-0962459-B1 | DIACETAL COMPOSITION, PROCESS FOR THE PREPARATION OF THE SAME, NUCLEATING AGENT FOR POLYOLEFINS CONTAINING THE SAME, POLYOLEFIN RESIN COMPOSITIONS, AND MOLDINGS | NEW JAPAN CHEM CO LTD (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20020028864-A1 | Diacetal composition, process for preparing the same, polyolefin nucleating agent containing said composition, polyolefin resing compositions and molded articles | KOBAYASHI TOSHIAKI (JP) | 2002-03-07 | — | — | US | disclosed |
| US-6245843-B1 | POWDER IN BINDER | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2001-06-12 | — | — | US | disclosed |
| EP-0962459-A1 | DIACETAL COMPOSITION, PROCESS FOR THE PREPARATION OF THE SAME, NUCLEATING AGENT FOR POLYOLEFINS CONTAINING THE SAME, POLYOLEFIN RESIN COMPOSITIONS, AND MOLDINGS | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260036547-A1 | METHODS FOR DETECTING METABOLITES USING A MICROFLUIDIC-BASED CE-MS SYSTEM | ATP5ME, ATP5MF, ATP5MK | ECE1 43/4885MEN1 3305/4885KMT2A 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.